SANGRIX INC. Class A Ordinary Shares
SGRX
0 hedge funds and large institutions have $3K invested in SANGRIX INC. Class A Ordinary Shares in 2020 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 3 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
99% less capital invested
Capital invested by funds: $390K → $3K (-$387K)
100% less funds holding
Funds holding: 3 → 0 (-3)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Squarepoint
New York
|
-$268K |
| 2 |
Jane Street
New York
|
-$61K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$48K |
SGRX Hedge Fund Activity: Q1 2020 in Review
0 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in SANGRIX INC. Class A Ordinary Shares (SGRX) for Q1 2020, worth a combined $3K — down 99% from $390K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of SGRX and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Squarepoint, exiting entirely with an estimated $268K sold.
- 0 institutional investors held SANGRIX INC. Class A Ordinary Shares (SGRX) as of Q1 2020, down from 3 in Q4 2019.
- Funds reported $3K of SANGRIX INC. Class A Ordinary Shares stock for Q1 2020, down 99% quarter-over-quarter.
- 0 funds opened new SANGRIX INC. Class A Ordinary Shares positions in Q1 2020 and 3 closed out, a net change of -3 holders.
- The largest SANGRIX INC. Class A Ordinary Shares seller in Q1 2020 was Squarepoint, an estimated $268K sold.
Based on aggregated 13F filings for Q1 2020.